EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor

Sprinzen, L., Garcia, F., Mela, A., Lei, L., Upadhyayula, P., Mahajan, A., Humala, N., Manier, L., Caprioli, R., Quiñones-Hinojosa, A., Casaccia, P., & Canoll, P. (2024). EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor. Cells, 13(3), 219. https://doi.org/10.3390/cells13030219

Authors:

Lisa M. Houghton

Franklin Garcia

Angeliki Mela

Lei Liang

Pavan S. Upadhyayula

Aayushi Mahajan

Nelson Humala

Lisa Manier

Richard M. Caprioli

Alfredo Quiñones‐Hinojosa

Patrizia Casaccia

Peter Canoll

Affiliated Authors:

Lisa M. Houghton

Franklin Garcia

Angeliki Mela

Lei Liang

Pavan S. Upadhyayula

Aayushi Mahajan

Nelson Humala

Peter Canoll

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Pathology and Cell Biology
- Department of Neurosurgery

Subjects:

Histone Deacetylase Inhibitors (MeSH)

Glioma (MeSH)

Biphenyl Compounds (MeSH)

Morpholines (MeSH)

Pyridones (MeSH)

Gliomas (OpenAlex Topic)

Epigenetic Modifications and Their Functional Implications (OpenAlex Topic)

Role of Histone Deacetylases in Cellular Regulation (OpenAlex Topic)

Author Keywords:

ezh2

hdac

idh1

gliomagenesis

opc

h3k27

Publication Type:

Article

Unique ID:

10.3390/cells13030219

PMID:

DOI:

10.3390/cells13030219

Journal:

Publication Date:

2024-01-25

Data Source:

OpenAlex

Source Link:

View OpenAlex Record

View PubMed Record

View Scopus Record

View Web of Science Record

Record Created:

Friday, July 26, 2024 - 09:29